The experts concluded that the new vaccine meets the standards of quality, safety and efficacy.
The World Health Organization (WHO ) reported, that it is increasing the reserve of the oral cholera vaccine. It is expected that after WHO issues a license to a third-party manufacturer, the supply of the drug will double. From now on immunization against cholera will be available in all countries and regions where there is a risk of contracting this disease. In the past , WHO was unable to meet the requests from the authorities of the Sudan and Haiti, due to a global shortage of the vaccine.
Until recently, there were two oral cholera vaccines approved by WHO (Dukoral® and Shanchol). Both vaccines are used in mass vaccination campaigns with support from WHO. The third vaccine was developed by South Korea. It passed all inspections and tests. Recently, WHO experts concluded that the new vaccine meets the standards of quality, safety and efficacy. The emergence of a third party manufacturer on the international market in 2016, will increase the supply to about 6 million doses of vaccine.
Cholera is an acute diarrheal disease that affects as many as 4.3 million people each year, and can kill a person within hours if it goes untreated. The WHO estimates that roughly 142,000 people die from cholera worldwide each year. WHO reminds us that cholera is endemic in more than 50 countries.